Zobrazeno 1 - 10
of 85
pro vyhledávání: '"V.V. Poltorak"'
Autor:
V.V. Poltorak
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 12, Iss 4.76, Pp 59-72 (2016)
This review examines the new formulation of insulin glargine (recombinant) in the form of injections 300 U/ml (Gla‑300, Toujeo®). Gla‑300 is a next generation basal insulin with a novel formulation of insulin glargin delivering the same amount o
Externí odkaz:
https://doaj.org/article/40532c6d3973434e8b9d190333c5b588
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 11, Iss 8.72, Pp 41-60 (2015)
This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®). Gla-300 is a next generation basal insulin with a novel formulation of insulin glargin deliver
Externí odkaz:
https://doaj.org/article/66e1c5a5b7604e9eb30f7d2a38a0a57d
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 11, Iss 7.71, Pp 22-35 (2015)
This review, consisting of two parts, considers a new formulation of insulin glargine (rDNA origin) in the form of injections 300 U/ml (Gla-300, Toujeo®). Gla-300 is a next generation basal insulin with a novel formulation of insulin glargin deliver
Externí odkaz:
https://doaj.org/article/46fa0988c29a4df0a0ac69162f35a849
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 11, Iss 1.65, Pp 87-97 (2015)
Обзор посвящен описанию молекулярных механизмов терапевтического действия комбинации пероральных антидиабетических препаратов «мет
Externí odkaz:
https://doaj.org/article/1b8c4428d2724f5abf8dfd2dd26805f1
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 10, Iss 3.59, Pp 15-21 (2014)
Prevention/delay of the development of vascular complications remains one of major challenges in treatment of diabetes mellitus. Epidemiological studies have shown lack of efficacy of stable glycemic control in patients with long-existing diabetes. T
Externí odkaz:
https://doaj.org/article/b75476c8613640a8beb308c1509df576
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 10, Iss 1.57, Pp 77-89 (2014)
The article provides an overview of data on the clinical efficacy of glimepiride (Amaryl®) in diabetes mellitus type 2: there are described the effect of glimepiride on insulin resistance, body weight, its antiatherogenic and antithrombotic effects,
Externí odkaz:
https://doaj.org/article/70cafdd7d2c841988cd5d3d524b73a34
Autor:
V.V. Poltorak, V.V. Lipson
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 9, Iss 6.54, Pp 61-70 (2013)
The article deals with problem of choice in the administration of brands and generics, a review of the literature on the bioequivalence of these drugs is provided.
Externí odkaz:
https://doaj.org/article/2d896fc83006460a8fae583133ca6fa9
Autor:
V.V. Poltorak
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 9, Iss 3.51, Pp 69-76 (2013)
The authors carried out review of the literature concerning the increased occurence of cardiovascular disease and mortality in patients with diabetes under conditions of inadequate glycemic control. There has been proved the possibility to define a g
Externí odkaz:
https://doaj.org/article/820ea9f76a6a4ec89efeab24acd2533b
The Phenomenon of Ischemic Preconditioning: the Effect of Glucose Imbalance and Antidiabetic Therapy
Autor:
V.V. Poltorak
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 9, Iss 2.50, Pp 68-74 (2013)
Externí odkaz:
https://doaj.org/article/fcdebf75cf144ddcbdadeade2a536de7
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 9, Iss 1.49, Pp 15-22 (2013)
ORIGIN — the longest and most extensive study on Lantus® use in patients with cardiovascular risk with diabetes mellitus (DM) type 2 in the early stages, as well as prediabetes, in which insulin therapy is not indicated now. ORIGIN trial was initi
Externí odkaz:
https://doaj.org/article/41dbd22128a540a390fec37a09213eb0